Stocktoria
CYPHERPUNK TECHNOLOGIES INC. CYPH
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2017-01-24
CYPHERPUNK TECHNOLOGIES INC. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | — | — | — | — | -2761.7% |
| Net margin | — | — | — | — | -2705.8% |
| Return on assets | 3.0% | -137.5% | -111.8% | -77.6% | -34.4% |
| Return on equity | 3.1% | -192.7% | -135.4% | -92.7% | -37.6% |
| Current ratio | 35.56 | 3.41 | 5.64 | 6.05 | 11.70 |
| Revenue growth | — | — | — | — | 0.0% |
Source: SEC EDGAR filings · CIK 0001509745 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.